AlphAIAlphAI — Financial news for AI agents
gurufocus.comOCT 202 min read$ISRG

Intuitive Surgical (ISRG) Settles da Vinci Robot Antitrust Case

Intuitive Surgical (ISRG) settled a da Vinci Surgical Robot antitrust case for $450 million, recording a third-quarter charge. The company agreed to injunctive relief pending court approval. ISRG is trading at $438, 31.1% below its GF Value of $635.52, with a GF Score of 96/100. Insiders sold $93.4 million in shares over 12 months.

Original reporting
gurufocus.com
Published Oct 20, 2026, 9:27 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 20, 2026, 10:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefRegulation
Primary signal
$ISRG
Bearish
high confidence
Mentioned
$ISRG
Relevance
7/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$ISRGBearishHigh
01

Why it matters

The $450 M settlement creates a near‑$1 per share earnings hit, likely prompting a short‑term price dip while the long‑term growth narrative stays intact.

02

Market read

A material legal settlement for a large‑cap med‑tech firm, directly affecting its upcoming earnings release.

03

What to watch

The charge is one‑time; underlying revenue streams from instruments and services remain strong.

Relevance 7/10Novelty 8/10Timing: today

Background

Intuitive Surgical is the leading maker of da Vinci surgical robots, with >10,000 units installed worldwide.

Company-level read

Ticker impact

$ISRGBearishHigh confidence
Context

Intuitive Surgical announced a $450 million antitrust settlement, creating a $0.99 per share after‑tax charge in Q3 2026.

Expected impact

downward pressure as investors price in the earnings hit

Evidence & confidence

A one‑time $450 M expense is material for a $154 B market‑cap company and directly reduces EPS.

Market effects

Sector

May raise concerns for other medical‑device firms facing regulatory scrutiny.

Regional

Limited to U.S. healthcare equities; no broad regional effect.

Global

Minimal global impact beyond the med‑tech sector.

Counterpoint

What could challenge this read

The settlement resolves litigation risk, potentially clearing the path for future growth and could be a buying opportunity at a discount.

Key entities

  • Company
    Intuitive Surgical Inc.

    NASDAQ‑listed maker of da Vinci surgical robots.

Read at source← All news

StoryIntuitive Surgical posts Q3 2026 results with revenue up 22% and a $450 million antitrust settlement charge

Also covered by

4 outlets

Related articles

OCT 20
$ISRGMedAI 8/10

Intuitive Surgical, Inc (ISRG) Q3 2026 Earnings Call Transcript

Intuitive Surgical (ISRG) reported Q3 2026 earnings, highlighting 15% total procedure growth, with 14% in da Vinci and 31% in Ion procedures. U.S. da Vinci growth was 10%, while international growth was 20%. The company installed over 13,200 da Vinci and Ion systems worldwide. Revenue growth was driven by strong demand for da Vinci 5 and SP platforms, with 28% increase in system placements. The company also announced plans for a new manufacturing facility in Malaysia.

news.alphastreet.com3 min
OCT 20
$ISRGMedAI 8/10

Intuitive Surgical (ISRG) Q3 Earnings Beat Expectations with Str

Intuitive Surgical (ISRG) reported Q3 earnings that surpassed expectations, with revenue of $3.05B, up 21.5% YoY, and EPS of $3.00. The company saw a 15% rise in procedures and placed 546 new da Vinci systems. ISRG's GF Value suggests it is undervalued by 31.1%, with a GF Score of 96/100. Insiders sold $93.4M in shares, while gurus show mixed activity.

gurufocus.com2 min
OCT 20
$ISRGHighAI 8/10

Stocks making the biggest moves after hours: Super Micro Computer, Intuitive Surgical, Netflix, SpaceX & more

Intuitive Surgical (ISRG) fell 10% after Q3 results missed expectations, while SpaceX shares rose 2% on a 161% revenue jump. Netflix (NFLX) dropped 5% despite in-line sales. Capital One (COF) gained 5% on higher net income. United Airlines (UAL) declined 2% after earnings trailed estimates. Super Micro Computer (SMCI) surged 12% on an upgraded revenue outlook.

cnbc.com2 min